These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18344973)

  • 21. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
    Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
    Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased protein kinase C gamma activity induces Purkinje cell pathology in a mouse model of spinocerebellar ataxia 14.
    Ji J; Hassler ML; Shimobayashi E; Paka N; Streit R; Kapfhammer JP
    Neurobiol Dis; 2014 Oct; 70():1-11. PubMed ID: 24937631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.
    Huynh DP; Figueroa K; Hoang N; Pulst SM
    Nat Genet; 2000 Sep; 26(1):44-50. PubMed ID: 10973246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2.
    Scoles DR; Meera P; Schneider MD; Paul S; Dansithong W; Figueroa KP; Hung G; Rigo F; Bennett CF; Otis TS; Pulst SM
    Nature; 2017 Apr; 544(7650):362-366. PubMed ID: 28405024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERK activation precedes Purkinje cell loss in mice with Spinocerebellar ataxia type 17.
    Lin CW; Fan CH; Chang YC; Hsieh-Li HM
    Neurosci Lett; 2020 Nov; 738():135337. PubMed ID: 32877710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analyses of Purkinje cell gene expression profiles reveal shared molecular abnormalities in models of different polyglutamine diseases.
    Friedrich B; Euler P; Ziegler R; Kuhn A; Landwehrmeyer BG; Luthi-Carter R; Weiller C; Hellwig S; Zucker B
    Brain Res; 2012 Oct; 1481():37-48. PubMed ID: 22917585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoplasmic and nuclear polyglutamine aggregates in SCA6 Purkinje cells.
    Ishikawa K; Owada K; Ishida K; Fujigasaki H; Shun Li M; Tsunemi T; Ohkoshi N; Toru S; Mizutani T; Hayashi M; Arai N; Hasegawa K; Kawanami T; Kato T; Makifuchi T; Shoji S; Tanabe T; Mizusawa H
    Neurology; 2001 Jun; 56(12):1753-6. PubMed ID: 11425948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies.
    Pérez Ortiz JM; Orr HT
    Adv Exp Med Biol; 2018; 1049():135-145. PubMed ID: 29427101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ataxic phenotype with altered Ca
    Hashiguchi S; Doi H; Kunii M; Nakamura Y; Shimuta M; Suzuki E; Koyano S; Okubo M; Kishida H; Shiina M; Ogata K; Hirashima F; Inoue Y; Kubota S; Hayashi N; Nakamura H; Takahashi K; Katsumoto A; Tada M; Tanaka K; Sasaoka T; Miyatake S; Miyake N; Saitsu H; Sato N; Ozaki K; Ohta K; Yokota T; Mizusawa H; Mitsui J; Ishiura H; Yoshimura J; Morishita S; Tsuji S; Takeuchi H; Ishikawa K; Matsumoto N; Ishikawa T; Tanaka F
    Neurobiol Dis; 2019 Oct; 130():104516. PubMed ID: 31229688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Status of Gene Therapy Research in Polyglutamine Spinocerebellar Ataxias.
    Afonso-Reis R; Afonso IT; Nóbrega C
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.
    Yang Y; Yang S; Guo J; Cui Y; Tang B; Li XJ; Li S
    J Neurosci; 2017 Sep; 37(38):9101-9115. PubMed ID: 28821675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of mutant mice that express polyglutamine in cerebellar Purkinje cells.
    Oue M; Mitsumura K; Torashima T; Koyama C; Yamaguchi H; Furuya N; Hirai H
    Brain Res; 2009 Feb; 1255():9-17. PubMed ID: 19103174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidation of the molecular mechanism and exploration of novel therapeutics for spinocerebellar ataxia caused by mutant protein kinase Cγ.
    Seki T; Adachi N; Abe-Seki N; Shimahara T; Takahashi H; Yamamoto K; Saito N; Sakai N
    J Pharmacol Sci; 2011; 116(3):239-47. PubMed ID: 21666345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ronin overexpression induces cerebellar degeneration in a mouse model of ataxia.
    Zwaka TP; Skowronska M; Richman R; Dejosez M
    Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34165550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term succinic acid treatment mitigates cerebellar mitochondrial OXPHOS dysfunction, neurodegeneration and ataxia in a Purkinje-specific spinocerebellar ataxia type 1 (SCA1) mouse model.
    Ferro A; Carbone E; Zhang J; Marzouk E; Villegas M; Siegel A; Nguyen D; Possidente T; Hartman J; Polley K; Ingram MA; Berry G; Reynolds TH; Possidente B; Frederick K; Ives S; Lagalwar S
    PLoS One; 2017; 12(12):e0188425. PubMed ID: 29211771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced Purkinje cell size is compatible with near normal morphology and function of the cerebellar cortex in a mouse model of spinocerebellar ataxia.
    Trzesniewski J; Altmann S; Jäger L; Kapfhammer JP
    Exp Neurol; 2019 Jan; 311():205-212. PubMed ID: 30312605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6.
    Jayabal S; Chang HH; Cullen KE; Watt AJ
    Sci Rep; 2016 Jul; 6():29489. PubMed ID: 27381005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. βIII spectrin controls the planarity of Purkinje cell dendrites by modulating perpendicular axon-dendrite interactions.
    Fujishima K; Kurisu J; Yamada M; Kengaku M
    Development; 2020 Dec; 147(24):. PubMed ID: 33234719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.